Medicine & Life Sciences
Combination Drug Therapy
100%
Sarcoma
93%
Anthracyclines
37%
Ifosfamide
27%
Neoplasms
24%
NAc-Sar-Gly-Val-(d-allo-Ile)-Thr-Nva-Ile-Arg-ProNEt
22%
trofosfamide
20%
Drug Therapy
19%
Trabectedin
17%
Bendamustine Hydrochloride
16%
Therapeutics
16%
Dermatofibrosarcoma
15%
Topoisomerase I Inhibitors
15%
Clinical Studies
15%
Thrombospondins
15%
Taxoids
14%
Dacarbazine
14%
Temozolomide
13%
Gastrointestinal Stromal Tumors
13%
Rhabdomyosarcoma
13%
Oceans and Seas
12%
Cytostatic Agents
12%
Imatinib Mesylate
12%
Translational Medical Research
12%
Porifera
12%
Oncogene Proteins
12%
gemcitabine
12%
DNA
12%
Bevacizumab
12%
TOR Serine-Threonine Kinases
12%
Standard of Care
10%
Protein-Tyrosine Kinases
10%
Neoplasm Metastasis
6%
Safety
6%